Recent Finacing
Recent Raise
Muvon Therapeutics develops an autologous muscle precursor cell therapy with adjunct electromagnetic stimulation to regenerate sphincter muscle for stress urinary incontinence, conducting phase 1 trials and automating manufacturing scale-up.
